Case Western Reserve University Awarded AHA Rapid Impact Research Award for Cardiac Arrest Recovery Study

The American Heart Association (AHA) has granted Case Western Reserve University a Rapid Impact Research Award to support urgent research into why the heart struggles to repair itself after cardiac arrest and to explore potential treatments. The findings may have implications for other serious conditions involving interrupted blood flow.

The Award and Research Focus

This AHA designation is applied to research considered urgent, high-priority, and capable of delivering results to patients quickly.

The project is led by Cody Rutledge, an assistant professor of medicine at Case Western Reserve University School of Medicine.

Background: The Scale of the Problem

According to AHA statistics cited in the research:

• Nearly 350,000 Americans experience a cardiac arrest outside of a hospital each year.
• Approximately one in ten of these individuals survive.
• Survivors face life-threatening heart damage and risk of death in the hours and days following resuscitation.

A Key Discovery

Rutledge's prior research identified a specific biological mechanism that may contribute to this poor recovery.

The research found that after cardiac arrest, the heart's repair system shuts down. Specifically, the mitochondrial ribosome—a cellular component that builds parts heart cells need to generate energy—stops working, leaving the heart unable to recover.

Research Objectives

The newly funded research team will now pursue two primary goals:

1. To confirm that suppressed mitochondrial protein production is a root cause of cardiac dysfunction after resuscitation.
2. To determine whether providing heart cells with specific nutrients and compounds can restore mitochondrial protein production and improve survival outcomes.

Broader Implications

In a statement, Cody Rutledge said, "Support from the American Heart Association will help us accelerate our research. Perhaps most exciting is that our findings extend well beyond cardiac arrest."

The molecular mechanisms under investigation involve damage that occurs when blood flow is cut off and then restored to an organ.

This process is central to other medical conditions such as heart attack and stroke during major surgery. The research suggests any new treatment developed could benefit patients experiencing these conditions in addition to those who suffer cardiac arrest.